Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
fda
2
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
abbvie
akouos
alex gorsky
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
ashley mcevoy
astrazeneca
auris health
biogen
bluerock therapeutics
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
clinical trials
covid-19
crispr
deerfield management
detroit blog main
detroit top stories
durvalumab
editas medicine
europe blog main
europe top stories
forty seven
What
deal
2
×
plans
2
×
acquiring
acquisitions
announced
auris
billion
bio
builds
buy
cash
ceo
collabs
company’s
covid
daniel
developer
gilead
gilead’s
health
help
introduce
ipo
johnson
medical
medicines
month
o’day
robotics
roundup
sciences
startup
stated
transformative
years
Language
unset
Current search:
plans
×
deal
×
fda
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B